Latest filing published 03 Nov 2021 for Aclaris Therapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Foresite Capital Management III, LLC: trading record in brief
Foresite Capital Management III, LLC is a declared insider of Aclaris Therapeutics, Inc., with filings sourced from SEC (Form 4). We count 2 filings, every one of them for a trade on 1 November 2021.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 3 November 2021 with a transaction in Aclaris Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Foresite Capital Management III, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,954,904 shares0Common StockSEC:0001209191-21-062697:0
1 of 1 declaration
